Menu

Pharma News

26 AA011066

India suffers HIV drug shortages

Home/Pharma News | Posted 10/10/2014

Supply bottlenecks and late payments to drugmakers have hit HIV treatment supplies across India, according to reports in the Indian press. The drug shortages, which affect those least able to pay, have seen some government distribution centres running out of drugs altogether.

Shaking hands V13D29

Biocad to be taken over by Russian investment firm

Home/Pharma News | Posted 02/06/2014

Russia’s biggest drugmaker, Pharmstandard, and investment company, Millhouse LLC, have said that they are planning to buy 70% of Russian biosimilars developer Biocad.

Business Aquisition V13F07

Amgen and Pfizer seek deal with Russian non-originator biologicals firm

Home/Pharma News | Posted 30/08/2013

Russian biotechnology company Biocad is reported to be attracting offers from US-based Pfizer and biotechnology giant Amgen.

Teamwork original

Strides and Shasun merger aims to spread risk

Home/Pharma News | Posted 03/10/2014

In the current climate of increasing scrutiny against Indian generics manufacturers by the US Food and Drug Administration (FDA), Indian generics maker Strides Arcolab (Strides) and India-based active pharmaceutical ingredient (API) maker Shasun Pharmaceuticals (Shasun) have announced a ‘risk-spreading’ merger.

53 MD002445

Cipla and S&D Pharma make generics deal for Czech Republic and Slovakia

Home/Pharma News | Posted 19/09/2014

India-based generics maker Cipla has partnered with S&D Pharma to launch affordable, high quality generics in the Czech Republic and Slovakia.

Drug shortages 3 V13k14

Patients at risk from UK drug shortages

Home/Pharma News | Posted 12/09/2014

Ongoing drug shortages in the UK have led to 80% of general practitioners (GPs) surveyed reporting that their workloads have increased in the last year. A third of doctors say their patients have been harmed or been negatively affected if a second choice has had to be prescribed.

Teamwork original

Investor principles on biosimilars gained support

Home/Pharma News | Posted 05/09/2014

Amgen and Novartis (parent company of Sandoz, a leader in the biosimilars field) have both come out in support of a set of principles on biosimilars laid down by a coalition of 19 institutional investors.

Label FDA V14b20

Branded drugmaker could be sued for generic’s side effects

Home/Pharma News | Posted 29/08/2014

The Alabama Supreme Court has ruled, for the second time, that Pfizer could be sued for damages allegedly caused by its heartburn drug Reglan (metoclopramide), even if the plaintiff had only taken a generic version of the drug. The ruling follows a rehearing requested by Pfizer, which failed to overturn the original ruling.

Drug Shortages FDA V13K15

Generics shortages continue to rise in the UK

Home/Pharma News | Posted 22/08/2014

There is growing anxiety around the supply of generic medicines in the UK, according to a statement released by the country’s All-Party Pharmacy Group (APPG). The problem is worse than it was two years ago [1], say the cross-bench Members of Parliament who make up the group, and it is not being addressed by the Department of Health’s (DoH) supply chain forum which was set up to address this very issue.

Business Aquisition V13F07

Generics deals for Mylan, Pfizer and Sun Pharma

Home/Pharma News | Posted 14/08/2014

Not to be beaten by biosimilars manufacturers, generics makers are also jumping on the ‘deals’ bandwagon, with a plethora of collaborations announced in the past weeks.